SG3 Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-29,000
Closed -$5.54M 478
2022
Q2
$5.54M Sell
29,000
-45,000
-61% -$7.94M 0.65% 33
2022
Q1
$15.3M Buy
74,000
+12,400
+20% +$2.04M 0.43% 44
2021
Q4
$11M Buy
61,600
+43,700
+244% +$8.62M 0.22% 83
2021
Q3
$3.69M Buy
+17,900
New +$3.51M 0.11% 184

Other funds holding SWAV

SG3 Management's SWAV Position: Q4 2022 in Review

SG3 Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2022, closing a stake of 10,000 shares — an estimated $2.78M sold.

SG3 Management first reported a position in SWAV in Q3 2022 and held it in 1 quarter. The position peaked at $2.78M in Q3 2022. 415 funds tracked by Wall St. Rank hold SWAV as of Q4 2022.

  • SG3 Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • SG3 Management sold 10,000 Shockwave Medical, Inc. Common Stock shares in Q4 2022, an estimated $2.78M.
  • SG3 Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • SG3 Management's Shockwave Medical, Inc. Common Stock position peaked at $2.78M in Q3 2022.
  • 415 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2022.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.